India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
How to check if you have breast cancer? Breast cancer is the main cancer in women. Breast cancer usually occurs in women, but this does not mean that men cannot develop breast cancer. Like women, men are also at risk of breast cancer. However, the risk of breast cancer in men is lower than in women. Out of 1,000 breast cancer patients, four to five, less than one percent, are seen in men. This cancer that develops from cells in the breast can occur in both men and women. If this cancer can be detected in time, the risk of death can be reduced. The main cause of breast cancer is heredity. If detected in time, it can be treated. According to the American Cancer Society, the death rate from breast cancer has been steadily decreasing over the last few years. It is said that with regular checkups and proper treatment, the risk of death from cancer is reduced. Also, with the help of early detection, additional risks from breast cancer can be avoided. There are different methods to detec...